David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
CALL
Bunge Global
BG
$21.5B
| $265K | ﹤0.01% |
+5,000
| New | +$265K |
|
|
AUD
3227
PUT
DELISTED
Audacy, Inc.
AUD
| $263K | ﹤0.01% |
50,000
| – | – |
|
|
VNE
3228
PUT
DELISTED
Veoneer, Inc.
VNE
| $263K | ﹤0.01% |
+11,500
| New | +$319K |
|
|
WUBA
3229
CALL
DELISTED
58.com Inc
WUBA
| $263K | ﹤0.01% |
4,000
-10,000
| -71% | -$630K |
|
3230
Stepan Co
SCL
$1.41B
| $262K | ﹤0.01% |
2,993
-188
| -6% | -$16.3K |
|
|
SRC
3231
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $262K | ﹤0.01% |
6,583
-8,155
| -55% | -$311K |
|
|
BLD
3232
DELISTED
TopBuild
BLD
| $261K | ﹤0.01% |
4,029
-90,112
| -96% | -$5.07M |
|
3233
Salesforce
CRM
$168B
| $261K | ﹤0.01% |
1,650
-19,557
| -92% | -$3.03M |
|
|
SRDX
3234
CALL
DELISTED
Surmodics
SRDX
| $261K | ﹤0.01% |
6,000
-10,300
| -63% | -$525K |
|
3235
PUT
Sun Communities
SUI
$15.3B
| $261K | ﹤0.01% |
+2,200
| New | +$245K |
|
|
MLNX
3236
PUT
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $260K | ﹤0.01% |
+2,200
| New | +$221K |
|
3237
Kadant
KAI
$3.58B
| $259K | ﹤0.01% |
2,947
-300
| -9% | -$25.8K |
|
3238
RenaissanceRe
RNR
$13.7B
| $258K | ﹤0.01% |
1,800
| – | – |
|
3239
PUT
Dycom Industries
DY
$10.6B
| $257K | ﹤0.01% |
+5,600
| New | +$307K |
|
3240
Future Fuel
FF
$236M
| $256K | ﹤0.01% |
19,098
-24,023
| -56% | -$408K |
|
|
SBNY
3241
CALL
DELISTED
Signature Bank
SBNY
| $256K | ﹤0.01% |
2,000
-18,000
| -90% | -$2.29M |
|
3242
CALL
Ryanair
RYAAY
$29.7B
| $255K | ﹤0.01% |
+8,500
| New | +$246K |
|
3243
LeMaitre Vascular
LMAT
$1.81B
| $254K | ﹤0.01% |
+8,207
| New | +$219K |
|
3244
LendingTree
TREE
$429M
| $254K | ﹤0.01% |
722
-31,617
| -98% | -$9.54M |
|
3245
Barnes & Noble Education
BNED
$437M
| $253K | ﹤0.01% |
603
+290
| +93% | +$157K |
|
3246
CALL
Oil States International
OIS
$506M
| $253K | ﹤0.01% |
+14,900
| New | +$252K |
|
|
LN
3247
DELISTED
LINE Corporation
LN
| $253K | ﹤0.01% |
7,190
-525
| -7% | -$18.9K |
|
3248
Harmony Gold Mining
HMY
$14.3B
| $252K | ﹤0.01% |
132,500
-450,795
| -77% | -$884K |
|
3249
MeiraGTx Holdings
MGTX
$1.43B
| $252K | ﹤0.01% |
+14,606
| New | +$206K |
|
|
SKX
3250
PUT
DELISTED
Skechers
SKX
| $252K | ﹤0.01% |
+7,500
| New | +$224K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.